Helfand BT - Search Results

1

Symptom Based Clustering of Women in the LURN Observational Cohort Study.

Andreev VP, Liu G, Yang CC, Smith AR, Helmuth ME, Wiseman JB, Merion RM, Weinfurt KP, Cameron AP, Lai HH, Cella D, Gillespie BW, Helfand BT, Griffith JW, DeLancey JOL, Fraser MO, Clemens JQ, Kirkali Z; LURN Study Group. Andreev VP, et al. Among authors: helfand bt. J Urol. 2018 Dec;200(6):1323-1331. doi: 10.1016/j.juro.2018.06.068. Epub 2018 Jul 7. J Urol. 2018. PMID: 29990467 Free PMC article.

2

Comparison of prostate specific antigen velocity in screened versus referred patients with prostate cancer.

Meeks JJ, Thaxton CS, Loeb S, Roehl KA, Helfand BT, Catalona WJ. Meeks JJ, et al. Among authors: helfand bt. J Urol. 2008 Apr;179(4):1340-3. doi: 10.1016/j.juro.2007.11.068. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289590 Clinical Trial.

3

Pathological outcomes associated with the 17q prostate cancer risk variants.

Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, Catalona WJ. Helfand BT, et al. J Urol. 2009 Jun;181(6):2502-7. doi: 10.1016/j.juro.2009.01.109. Epub 2009 Apr 16. J Urol. 2009. PMID: 19371897 Free PMC article.

4

Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial.

Helfand BT, Mongiu AK, Roehrborn CG, Donnell RF, Bruskewitz R, Kaplan SA, Kusek JW, Coombs L, McVary KT; MIST Investigators. Helfand BT, et al. J Urol. 2009 Jun;181(6):2674-9. doi: 10.1016/j.juro.2009.02.032. Epub 2009 Apr 16. J Urol. 2009. PMID: 19375101 Free PMC article.

5

A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patients.

Helfand BT, Evans RM, McVary KT. Helfand BT, et al. Eur Urol. 2010 Apr;57(4):586-91. doi: 10.1016/j.eururo.2009.12.025. Epub 2009 Dec 28. Eur Urol. 2010. PMID: 20036783

6

Determining the utility of recalled lower urinary tract symptoms.

Helfand BT, Fought A, Manvar AM, McVary KT. Helfand BT, et al. Urology. 2010 Aug;76(2):442-7. doi: 10.1016/j.urology.2009.12.052. Epub 2010 Mar 25. Urology. 2010. PMID: 20346488

7

Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity.

Helfand BT, Blackwell RH, McVary KT. Helfand BT, et al. J Urol. 2010 Jul;184(1):218-23. doi: 10.1016/j.juro.2010.03.020. Epub 2010 May 16. J Urol. 2010. PMID: 20483154

8

Holmium laser ablation and enucleation of the prostate: a pilot study of the hybrid technique.

Helfand BT, Manvar AM, Auffenberg GB, Blackwell R, Hartman RJ, McVary KT. Helfand BT, et al. Can J Urol. 2010 Jun;17(3):5190-4. Can J Urol. 2010. PMID: 20566012

9

Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.

Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, Catalona WJ. Helfand BT, et al. J Urol. 2010 Aug;184(2):501-5. doi: 10.1016/j.juro.2010.04.032. Epub 2010 Jun 17. J Urol. 2010. PMID: 20620408 Free PMC article.

10

Delay of surgery in men with low risk prostate cancer.

O'Brien D, Loeb S, Carvalhal GF, McGuire BB, Kan D, Hofer MD, Casey JT, Helfand BT, Catalona WJ. O'Brien D, et al. Among authors: helfand bt. J Urol. 2011 Jun;185(6):2143-7. doi: 10.1016/j.juro.2011.02.009. Epub 2011 Apr 15. J Urol. 2011. PMID: 21496847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

227 results

Search Page